流式细胞仪市场Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Reagents & Consumables, Software, Accessories, Services), By Technology (Cell-based, Bead-based), By Application (Research, Industrial, Clinical), By End-Use, By Region; Segment Forecast, 2021 - 2028

报告摘要

全球流式细胞仪市场于2020年的6.38亿美元估价，预计预测期内的CAGR 9.0％。流式细胞仪技术进步，使用流式细胞术技术在科学研究和药物检测中，强调发展生物学和免疫肿瘤学研究，AI平台在流式细胞术界面和流式细胞术软件软件中的创新中的集成，以及黑素瘤的高发率均驾驶市场增长。

了解有关此报告的更多信息：request for sample pages

扩大市场在发展中国家，扩增干细胞研究，接受重组DNA技术对抗体制造，以及串联流式细胞术技术的进展是所有要考虑的因素。

Industry Dynamics

Growth Drivers
在预计期间可能推动市场对流式细胞术的需求的因素之一是慢性障碍的普遍性。此外，化疗和放射治疗在癌症护理中的负面影响增加了医生对自我和同种异体干细胞疗法的偏好，提高了市场的发展。

根据WCRF，2018年，大约1800万人被诊断为全球癌症诊断。在那一年，诊断出约17,036,901例新病例。根据WCRF的说法，2018年用白血病鉴定了约437,033人。流式细胞术有助于白血病的鉴定和治疗，以及来自髓性白血病的淋巴水的分化。

Due to the healthcare spending in developed countries and improved healthcare facilities, the biotechnology industry is expected to expand significantly over the forecast period. The market is expected to be driven by an increase in government support for clinical trials about in vitro molecular diagnostics, as it plays a critical role in the production of new drugs.

Significant market growth of flow cytometry has resulted from increased investments in influential biotech and biopharma firms. In comparison to the U.S., Chinese investors are increasingly focused on European biotech firms.

流式细胞仪市场报告范围

该市场主要基于产品，技术，应用，最终用途和地区分段。

由产品	通过技术	通过申请	通过最终使用	按地区
Instruments 试剂和耗材 Software Accessories Service	基于细胞的 珠子为基础	研究 Industrial 临床	商业组织 医院 学术研究所 临床测试实验室	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

Insight by Product

The instruments segment dominated the global market for flow cytometry in 2020, accounting for the largest revenue share, and is anticipated to continue to do so during the forecast period. This high market share can be attributed to technological advances and the launch of new cytometers by key market players. The high cost of these instruments also contributes to the segment's market growth.

技术洞察力

2020年,基于单元的技术主导市场t. The market growth is due to an increase in demand for early diagnosis and increased understanding of the related benefits of cell-based assays. Besides, advances in cell-based assay technology, such as innovations in tools, labels, software, affinity reagents, and algorithms, are likely to accelerate adoption soon.

应用洞察力

The research application of flow cytometry accounted for the significant market value in 2020 and is likely to be the largest segment in the given time frame. Increased R&D activities in cancer and communicable diseases, like COVID-19, can be due to this high share. Furthermore, rising R&D investments in the pharmaceutical and biotechnology industries are projected to add a favorable climate for business expansion.

Insight by End-Use

In 2020, the commercial organization category dominated the market. Increased R&D efforts by commercial entities such as pharmaceutical and biotechnology firms are credited with this supremacy. Furthermore, growing food industries in emerging countries like China and India are expected to boost segment growth.

Geographic Overview

北美洲占2020年全球流式细胞术市场的最高收入份额。这种支配地位是由于美国高医疗支出，发达的医疗保健系统，以及流动细胞筛的采用上升。betway体育亚洲版入口

此外，学术机构和制药公司的研究活动诱导了在研究目的中采用流式细胞术解。此外，长期和传染性疾病的高发病率，例如冠状病毒，增加了对流式细胞术的需求。

Due to the rapid growth of the biopharmaceutical industry in emerging markets such as China and India, the demand for flow cytometry in Asia Pacific is anticipated to expand at an exponential rate. Ongoing R&D activities in the fields of cancer and infectious diseases.

例如，Covid-19预计将推动该地区流式细胞术产品的需求。此外，区域市场参与者正在进行全面的研究，以增强或创造新的流式细胞术溶液。

竞争洞察力

Key players in the flow cytometry market are concentrating their energies on strategic acquisitions to boost their research & development capabilities, which will help them provide creative solutions to users and gain a competitive edge.

丹纳赫公司等市场参与者;SYSMEX公司;Luminex Corporation;Bio-Rad Laboratories，Inc。;EMD Millipore;Miltenyi Biotec，Inc。;Becton，Dickinson和公司;Affymetrix公司;Thermo Fischer Scientific;And Agilent Technologies，Inc。是流式细胞术市场的一些公司。